Our History

Recognizing the potential for soluble thin films to deliver active pharmaceutical ingredients, ARx became a global leader of the dosage form with the launch of over-the-counter pharmaceutical products and has been a commercial drug manufacturer for over 15 years. Since the technology first debuted, the thin film dosage form has expanded to include buccal and sublingual delivery applications and ARx has shifted its focus to prescription applications in both the branded and generic drug markets.

Through Adhesives Research, ARx is able to leverage over 60 years of drug formulation and coating expertise, as well as 30 years’ experience in the development and manufacture of adhesive formulations for the transdermal patch industry. The relationships formed over the years have provided us with a unique advantage and deep understanding of the drug delivery systems and market needs.

Established in 1961, the humble beginnings of Adhesives Research originated in a converted garage to develop and supply specialty adhesive-coated materials and processing equipment to meet the evolving needs of the graphics arts label market. Through several moves and expansions, Adhesives Research grew steadily, developing new capabilities and technologies that enabled the company to address the unmet needs of new markets. Rapid growth led to facility expansions to include the U.S., South America (1980), Europe (1999), and Asia (2000). With headquarters in Glen Rock, Pennsylvania, and Limerick, Ireland, today the company’s facilities span over 250 acres, cover over 300,000+ square feet of development and manufacturing space and employ approximately 300 associates. Today ARx remains an independent company, committed to working with customers as partners in the development of application-specific products that fill their unmet material needs.

ARx, LLC., is a global leader in the development and manufacture of specialty pharmaceutical products. Our dosage forms and drug delivery systems include oral and mucosal thin dissolvable films and transdermal patches. We partner with both generic and branded drug companies to deliver products that offer enhanced drug therapeutic effects, convenience to the patient, and market differentiation, while priding ourselves on being a true partner.

ARx approaches each project in a flexible manner, with the ability to meet individual client and project needs. The team follows five core guiding principles:

• To be the best there is in the heart of our business.

• To have a work environment that treats everyone with respect and actively fosters both teamwork and individual development.

• To be the most effective company in our field at partnering with our customers in developing and producing specialized products.

• To have profitable growth so that we can continuously improve and increase our capabilities.

• To talk straight and do what we say we are going to do.

We partner with our customers from prototype feasibility to commercial drug manufacturing. This also includes drug development and formulation, analytical method development & validation, clinical unit production, process development, registration, CMC filing support, and product validation. The ARx team leverages their foundation knowledge in thin dissolvable film and transdermal patches to ensure success at each step of the process.

Please contact us for further information regarding the benefits our partnership and technologies for your potential application.